GlaxoSmithKline PLC Director/PDMR Shareholding (9257J)
16 Abril 2020 - 8:21AM
UK Regulatory
TIDMGSK
RNS Number : 9257J
GlaxoSmithKline PLC
16 April 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms E Walmsley
==== ===================================== ====================================================
b) Position/status Chief Executive Officer
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.4420 970
========================================== =========================== =====================
GBP 15.4420 965
=========================== =====================
GBP 15.4420 777
=========================== =====================
d) Aggregated information 2,712
====
Aggregated volume GBP15.4420
Price
========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Dr H Barron
==== ======================================= ===================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 38.8800 559
============================================ ========================= ======================
$38.8800 439
========================= ======================
d) Aggregated information 998
====
Aggregated volume $38.8800
Price
============================================ ===================================================
e) Date of the transaction 2020-04-14
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr R Connor
==== ===================================== ====================================================
b) Position/status President, Global Vaccines
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.4420 205
========================================== =========================== =====================
GBP 15.4420 253
=========================== =====================
GBP 15.4420 245
=========================== =====================
d) Aggregated information 703
====
Aggregated volume GBP15.4420
Price
========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Ms D Conrad
==== ===================================== ======================================================
b) Position/status SVP Human Resources
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.4420 101
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== ============================
e) Date of the transaction 2020-04-14
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr J Ford
==== ====================================== ======================================================
b) Position/status Senior Vice President and General Counsel
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.4420 144
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2020-04-14
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr J Ford
==== ======================================= ====================================================
b) Position/status Senior Vice President and General Counsel
==== ======================================= ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 38.8800 48
========================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
======================================== ========================================================
e) Date of the transaction 2020-04-14
==== ======================================= ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr N Hirons
==== ===================================== ====================================================
b) Position/status SVP, Global Ethics & Compliance
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.4420 107
========================================== =========================== =====================
GBP 15.4420 106
=========================== =====================
GBP 15.4420 76
=========================== =====================
d) Aggregated information 289
====
Aggregated volume GBP 15.4420
Price
========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Ms S Jackson
==== ===================================== ======================================================
b) Position/status SVP, Global Communications & CEO Office
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.4420 61
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume GBP 15.4420
Price
===================================== ===========================================================
e) Date of the transaction 2020-04-14
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr I Mackay
==== ===================================== ======================================================
b) Position/status Chief Financial Officer
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.4420 524
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume GBP 15.4420
Price
===================================== ===========================================================
e) Date of the transaction 2020-04-14
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr B McNamara
==== ======================================= ===================================================
b) Position/status CEO, GSK Consumer Healthcare
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== --------------------------------------- ========================= ======================
$ 38.8800 100
-------------------------------------------- ========================= ======================
$ 38.8800 94
========================= ======================
$ 38.8800 80
------------------------- ----------------------
d) Aggregated information 274
====
Aggregated volume $ 38.8800
Price
============================================ ===================================================
e) Date of the transaction 2020-04-14
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr L Miels
==== ====================================== ====================================================
b) Position/status President, Global Pharmaceuticals
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.4420 195
=========================================== ========================== ======================
GBP15.4420 269
========================== ======================
GBP15.4420 235
========================== ======================
d) Aggregated information 699
====
Aggregated volume GBP15.4420
Price
=========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr D Redfern
==== ====================================== ====================================================
b) Position/status Chief Strategy Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.4420 199
=========================================== ========================== ======================
GBP15.4420 239
========================== ======================
GBP15.4420 172
========================== ======================
d) Aggregated information 610
====
Aggregated volume GBP15.4420
Price
=========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr R Simard
==== ====================================== ====================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.4420 86
=========================================== ========================== ======================
GBP15.4420 122
========================== ======================
d) Aggregated information 208
====
Aggregated volume GBP15.4420
Price
=========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms K Terrell
==== ======================================= ===================================================
b) Position/status Chief Digital & Technology Officer
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 38.8800 33
============================================ ========================= ======================
$ 38.8800 119
========================= ======================
$38.8800 82
========================= ======================
d) Aggregated information 234
====
Aggregated volume $ 38.8800
Price
============================================ ===================================================
e) Date of the transaction 2020-04-14
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr P Thomson
==== ====================================== ====================================================
b) Position/status President, Global Affairs
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 April 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.4420 134
=========================================== ========================== ======================
GBP15.4420 140
========================== ======================
GBP15.4420 99
========================== ======================
d) Aggregated information 373
====
Aggregated volume GBP15.4420
Price
=========================================== ====================================================
e) Date of the transaction 2020-04-14
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHXQLFFBZLFBBK
(END) Dow Jones Newswires
April 16, 2020 09:21 ET (13:21 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024